Partner news
News
Partner news
Cue Health Closes $100 Million Series C Financing to Support Launch of Rapid Molecular Testing Platform
Read full storyPartner news
HistoSonics Announces $40 Million Financing
Read full storyPartner news
Imec collaborates with Janssen to advance precision medicine to treat and eliminate disease
Read full storyPartner news
DayTwo Secures $31 Million In Series B Financing To Scale Microbiome Research Platform To Address Chronic Health Conditions
Read full storyPartner news
Medicines Discovery Catapult, MQ: Transforming mental health and Alzheimer’s Research UK announce an innovative drug discovery consortium with industry, supported by the Wellcome Trust.
Read full storyOther news
Genmab Signs Agreement with Janssen for Next-Generation CD38 Antibody, HexaBody®-CD38
Read full storyPartner news
Navitor Pharmaceuticals Initiates a Clinical Study of NV-5138, a Novel, Oral Small Molecule for Treatment-Resistant Depression
Read full storyPartner news
Dreem Announces $35 Million Financing from lead investors Johnson & Johnson Innovation – JJDC, Inc. (JJDC) and Bpifrance to Accelerate Innovations in the Field of Sleep Science
Read full storyPartner news
Evolve BioSystems Announces $40 Million Series C Financing to Expand its Flagship Infant Probiotic Product Evivo
Read full storyPartner news
E-Scape Bio Obtains Worldwide Rights from AbbVie for Selective S1P5 Program Targeting CNS-related Lysosomal Storage Disorders
Read full storyPartner news
Israel's Zebra Medical Vision raises $30 million
Read full storyPartner news
BlackThorn Therapeutics Initiates Phase 1 Study of BTRX-335140, an Investigational Kappa Opioid Receptor (KOR) Antagonist
Read full storyPartner news
Provention Bio, Inc. Secures $28.4 Million Founding Financing to Fund Development Targeting the Interception and Prevention of Immune-Mediated Disease
Read full storyPartner news